89-018-878

mitogen-activated protein kinase kinase kinase 14, Rabbit, Purified MaxPab™ Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-018-878-Each-of-1 In Stock ₹ 49,662.00

89-018-878 - Each of 1

₹ 49,662.00

In Stock

Quantity

1

Base Price: ₹ 49,662.00

GST (18%): ₹ 8,939.16

Total Price: ₹ 58,601.16

Antigen

mitogen-activated protein kinase kinase kinase 14

Classification

Polyclonal

Description

Rabbit polyclonal antibody raised against a full-length human MAP3K14 protein.

Gene

MAP3K14

Gene Alias

FTDCR1B/HS/HSNIK/NIK

Host Species

Rabbit

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Applications

Immunofluorescence, In situ PLA, Western Blot

Conjugate

Unconjugated

Formulation

PBS with no preservative; pH 7.4

Gene Accession No.

BC035576.1

Gene Symbols

MAP3K14

Immunogen

MAP3K14 (NP_003945.2, 1 a.a. ∼ 947 a.a) full-length human protein.

Quantity

100 μg

Research Discipline

Kinases

Gene ID (Entrez)

9020

Content And Storage

Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Isotype

IgG

Related Products

Img

Abnova Corporation

89-018-385

--

Img

Abnova Corporation

89-018-445

--

Img

Abnova Corporation

89-018-383

--

Img

Abnova Corporation

89-018-752

--

Img

Abnova Corporation

89-018-713

--

Img

Abnova Corporation

89-018-516

--

Img

Abnova Corporation

89-018-626

--

Img

Abnova Corporation

89-018-465

--

Description

  • This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase
  • This kinase binds to TRAF2 and stimulates NF-kappaB activity
  • It shares sequence similarity with several other MAPKK kinases
  • It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor
  • [provided by RefSeq Sequence: MAVMEMACPGAPGSAVGQQKELPKAKEKTPPLGKKQSSVYKLEAVEKSPVFCGKWEILNDVITKGTAKEGSEAGPAAISIIAQAECENSQEFSPTFSERIFIAGSKQYSQSESLDQIPNNVAHATEGKMARVCWKGKRRSKARKKRKKKSSKSLAHAGVALAKPLPRTPEQESCTIPVQEDESPLGAPYVRNTPQFTKPLKEPGLGQLCFKQLGEGLRPALPRSELHKLISPLQCLNHVWKLHHPQDGGPLPLPTHPFPYSRLPHPFPFHPLQPWKPHPLESFLGKLACVDSQKPLPDPHLSKLACVDSPKPLPGPHLEPSCLSRGAHEKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQANYHQTLHAQPRELSPRAPGPRPAEETTGRAPKLQPPLPPEPPEPNKSPPLTLSKEESGMWEPLPLSSLEPAPARNPSSPERKATVPEQELQQLEIELFLNSLSQPFSLEEQEQILSCLSIDSLSLSDDSEKNPSKASQSSRDTLSSGVHSWSSQAEARSSSWNMVLARGRPTDTPSYFNGVKVQIQSLNGEHLHIREFHRVKVGDIATGISSQIPAAAFSLVTKDGQPVRYDMEVPDSGIDLQCTLAPDGSFAWSWRVKHGQLENRP